33 results on '"Gmyrek, D."'
Search Results
2. Zur Fanconi-Anämie (FA): Analyse von 129 beschriebenen Fällen
3. Chromosomenaberrationen und Stoffwechselstörungen der Blutzellen bei Fanconi-Anämie vor und nach Übergang in Leukose am Beispiel einer Patientin
4. Studien zur Hämolyse bei der Fanconi-Anämie
5. Studien zur Hämolyse bei der Fanconi-Anämie
6. Chromosomenaberrationen und Stoffwechselstörungen der Blutzellen bei Fanconi-Anämie vor und nach Übergang in Leukose am Beispiel einer Patientin
7. Quantitative Beziehungen zwischen serochemischen des histologischen Befunden bei Hepatitis infectiosa
8. [Drug prevention of hyperbilirubinemia of the newborn. 3. Electron microscopic liver findings after treatment with phenylbutazone].
9. [Studies of various substances and substance classes on induction properties. 3. Chlorinated insecticides].
10. ["Liver involvement in mucoviscidosis". Published in issue 51-1971 of this journal. Reply to the opinion of G. Roschlau].
11. [Clinical aspects of Rh incompatibility. II. Discrepancy between high anti-D titer and incipient mild hemolytic disease of the newborn].
12. [Drug prevention of hyperbilirubinemia in newborn infants. IV. Possibility of early prognosis of hyperbilirubinemia in newborn infants using urinary sex steroids].
13. [Results of an oral loading test with paracetamol in childhood infectious hepatitis].
14. [Comparative studies on the value of wofaverdin and bromsulfophtalein in childhood].
15. [On the familial occurrence of Fanconi anemia and thrombocytopenia with malformations (remarks on the therapy of Fanconi anemia)].
16. [Percutaneous liver biopsy in children I. Methodology, indications, complications, contraindications].
17. [Drug prevention of hyperbilirubinemia in newborn infants. 5. Cumulative effect of the combination of the inductors phenobarbital and nikethamide].
18. [Enzyme induction in newborn infants--principles of medicamentous prevention of hyperbilirubinemia].
19. [ON FANCONI'S ANEMIA. ANALYSIS OF 129 CASES].
20. [Quantitative relations between biochemical and histological findings in infectious hepatitis].
21. [Drug prophylaxis of newborn hyperbilirubinemia. 1. Influence of phenylbutazone on the bilirubin level and extracellular space].
22. [Clinical aspects of Rh incompatibility. I. Transient disorders of erythropoiesis as a result of persistent Rh-antibodies after exchange transfusion].
23. [Medicamentous prevention of hyperbilirubinemia of the newborn. II. Influence of the inductor phenylbutazone on loading with paracetamol in newborn].
24. HAEMOLYSIS IN FANCONI'S ANAEMIA. INCREASED ATP-ASE AS A POSSIBLE CAUSE OF REDUCED ATP LEVELS.
25. [Medicamentous prevention of hyperbilirubinemia in newborn infants. VII. Development of a screening test for the early diagnosis of hyperbilirubinemia using multi-dimensional analysis of variance and discriminant analysis].
26. [Prevention of newborn infant hyperbilirubinemia by use of drugs. 8. Recommendation for the use of prevention in combination with a screening test for prognosis].
27. [Role of the liver in mucoviscidosis (cystic fibrosis). Results of clinical and biopsy studies].
28. Chromosomal aberrations and abnormalities of red-cell metabolism in a case of Fanconi's anaemia before and after development of leukaemia.
29. [Prevention by use of drugs of hyperbilirubinemia in the newborn. VI. Animal experiments and clinical tests of Vasalgin].
30. [Paracetamol loading in the evaluation of the developing glucuronization function in premature infants].
31. [Biopsy and clinical studies on liver damage in RH incompatitility].
32. [On the serology of blood groups A1 and A2].
33. [Percutaneous liver biopsy in children. 2. Results].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.